Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs

H. Nakamoto, H. Suzuki, M. Murakami, Y. Kageyama, A. Ohishi, Keiichi Fukuda, S. Hori, T. Saruta

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

1. The effects of endothelin on systemic and renal haemodynamics and plasma concentrations of neuroendocrine hormones including plasma renin activity, aldosterone, adrenocorticotropic hormone, cortisol, catecholamines and arginine vasopressin were investigated in 18 conscious dogs. 2. Bolus injection of 4 pmol of endothelin/kg did not cause any significant changes in haemodynamics. Mean arterial pressure was elevated by both doses of 40 pmol/kg [91 ± 2 to 99 ± 2 mmHg (12.1 ± 0.3 to 13.2 ± 0.3 kPa), P < 0.05] or 200 pmol/kg [93 ± 2 to 107 ± 3 mmHg (12.4 ± 0.3 to 14.3 ± 0.4 kPa), P < 0.01], the latter dose increasing cardiac output (14%, P < 0.05) and heart rate (9%, P < 0.05), and the former reducing these parameters (14% and 8%, P < 0.05, respectively). 3. In contrast with the various changes in systemic haemodynamics, renal blood flow transiently increased immediately after bolus injection in a dose-dependent manner (28%, P < 0.05, 50%, P < 0.01 and 110%, P < 0.01 with 4, 40 and 200 pmol of endothelin/kg, respectively). This transient elevation of renal blood flow was followed by a gradual decrease (16%, P < 0.05; 31%, P < 0.01 and 36%, P < 0.01) at 10 min. 4. All neurohormones were elevated in a dose-dependent manner. 5. Among these hormones, arginine vasopressin and plasma renin activity reached a peak level at 5 min (from 2.21 ± 0.45 to 6.37 ± 0.60 pmol/l, P < 0.01, and from 0.65 ± 0.08 to 1.09 ± 0.10 pmol of angiotensin I h-1 ml-1 P < 0.01, respectively) after bolus injection of 200 pmol of endothelin/kg, whereas adrenocorticotropic hormone and cortisol reached a peak level at 15 min (from 6.0 ± 0.7 to 18.2 ± 1.5 pmol/l, P < 0.01, and from 4.4 ± 0.9 to 16.5 ± 2.7 x 10-2 μmol/l, P < 0.01, respectively). 6. These results suggest that endothelin is a potent vasoconstrictive peptide in vivo with a marked effect on the renal vascular system, and that it induces elevation of vasoactive hormones directly and/or through central effects.

Original languageEnglish
Pages (from-to)567-572
Number of pages6
JournalClinical Science
Volume77
Issue number5
Publication statusPublished - 1989

Fingerprint

Endothelins
Hemodynamics
Hormones
Dogs
Kidney
Arginine Vasopressin
Renal Circulation
Renin
Adrenocorticotropic Hormone
Injections
Hydrocortisone
Angiotensin I
Aldosterone
Cardiac Output
Catecholamines
Neurotransmitter Agents
Blood Vessels
Arterial Pressure
Heart Rate
Peptides

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nakamoto, H., Suzuki, H., Murakami, M., Kageyama, Y., Ohishi, A., Fukuda, K., ... Saruta, T. (1989). Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs. Clinical Science, 77(5), 567-572.

Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs. / Nakamoto, H.; Suzuki, H.; Murakami, M.; Kageyama, Y.; Ohishi, A.; Fukuda, Keiichi; Hori, S.; Saruta, T.

In: Clinical Science, Vol. 77, No. 5, 1989, p. 567-572.

Research output: Contribution to journalArticle

Nakamoto, H, Suzuki, H, Murakami, M, Kageyama, Y, Ohishi, A, Fukuda, K, Hori, S & Saruta, T 1989, 'Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs', Clinical Science, vol. 77, no. 5, pp. 567-572.
Nakamoto, H. ; Suzuki, H. ; Murakami, M. ; Kageyama, Y. ; Ohishi, A. ; Fukuda, Keiichi ; Hori, S. ; Saruta, T. / Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs. In: Clinical Science. 1989 ; Vol. 77, No. 5. pp. 567-572.
@article{6724455ce925427e98e6fa885f5854af,
title = "Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs",
abstract = "1. The effects of endothelin on systemic and renal haemodynamics and plasma concentrations of neuroendocrine hormones including plasma renin activity, aldosterone, adrenocorticotropic hormone, cortisol, catecholamines and arginine vasopressin were investigated in 18 conscious dogs. 2. Bolus injection of 4 pmol of endothelin/kg did not cause any significant changes in haemodynamics. Mean arterial pressure was elevated by both doses of 40 pmol/kg [91 ± 2 to 99 ± 2 mmHg (12.1 ± 0.3 to 13.2 ± 0.3 kPa), P < 0.05] or 200 pmol/kg [93 ± 2 to 107 ± 3 mmHg (12.4 ± 0.3 to 14.3 ± 0.4 kPa), P < 0.01], the latter dose increasing cardiac output (14{\%}, P < 0.05) and heart rate (9{\%}, P < 0.05), and the former reducing these parameters (14{\%} and 8{\%}, P < 0.05, respectively). 3. In contrast with the various changes in systemic haemodynamics, renal blood flow transiently increased immediately after bolus injection in a dose-dependent manner (28{\%}, P < 0.05, 50{\%}, P < 0.01 and 110{\%}, P < 0.01 with 4, 40 and 200 pmol of endothelin/kg, respectively). This transient elevation of renal blood flow was followed by a gradual decrease (16{\%}, P < 0.05; 31{\%}, P < 0.01 and 36{\%}, P < 0.01) at 10 min. 4. All neurohormones were elevated in a dose-dependent manner. 5. Among these hormones, arginine vasopressin and plasma renin activity reached a peak level at 5 min (from 2.21 ± 0.45 to 6.37 ± 0.60 pmol/l, P < 0.01, and from 0.65 ± 0.08 to 1.09 ± 0.10 pmol of angiotensin I h-1 ml-1 P < 0.01, respectively) after bolus injection of 200 pmol of endothelin/kg, whereas adrenocorticotropic hormone and cortisol reached a peak level at 15 min (from 6.0 ± 0.7 to 18.2 ± 1.5 pmol/l, P < 0.01, and from 4.4 ± 0.9 to 16.5 ± 2.7 x 10-2 μmol/l, P < 0.01, respectively). 6. These results suggest that endothelin is a potent vasoconstrictive peptide in vivo with a marked effect on the renal vascular system, and that it induces elevation of vasoactive hormones directly and/or through central effects.",
author = "H. Nakamoto and H. Suzuki and M. Murakami and Y. Kageyama and A. Ohishi and Keiichi Fukuda and S. Hori and T. Saruta",
year = "1989",
language = "English",
volume = "77",
pages = "567--572",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "5",

}

TY - JOUR

T1 - Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs

AU - Nakamoto, H.

AU - Suzuki, H.

AU - Murakami, M.

AU - Kageyama, Y.

AU - Ohishi, A.

AU - Fukuda, Keiichi

AU - Hori, S.

AU - Saruta, T.

PY - 1989

Y1 - 1989

N2 - 1. The effects of endothelin on systemic and renal haemodynamics and plasma concentrations of neuroendocrine hormones including plasma renin activity, aldosterone, adrenocorticotropic hormone, cortisol, catecholamines and arginine vasopressin were investigated in 18 conscious dogs. 2. Bolus injection of 4 pmol of endothelin/kg did not cause any significant changes in haemodynamics. Mean arterial pressure was elevated by both doses of 40 pmol/kg [91 ± 2 to 99 ± 2 mmHg (12.1 ± 0.3 to 13.2 ± 0.3 kPa), P < 0.05] or 200 pmol/kg [93 ± 2 to 107 ± 3 mmHg (12.4 ± 0.3 to 14.3 ± 0.4 kPa), P < 0.01], the latter dose increasing cardiac output (14%, P < 0.05) and heart rate (9%, P < 0.05), and the former reducing these parameters (14% and 8%, P < 0.05, respectively). 3. In contrast with the various changes in systemic haemodynamics, renal blood flow transiently increased immediately after bolus injection in a dose-dependent manner (28%, P < 0.05, 50%, P < 0.01 and 110%, P < 0.01 with 4, 40 and 200 pmol of endothelin/kg, respectively). This transient elevation of renal blood flow was followed by a gradual decrease (16%, P < 0.05; 31%, P < 0.01 and 36%, P < 0.01) at 10 min. 4. All neurohormones were elevated in a dose-dependent manner. 5. Among these hormones, arginine vasopressin and plasma renin activity reached a peak level at 5 min (from 2.21 ± 0.45 to 6.37 ± 0.60 pmol/l, P < 0.01, and from 0.65 ± 0.08 to 1.09 ± 0.10 pmol of angiotensin I h-1 ml-1 P < 0.01, respectively) after bolus injection of 200 pmol of endothelin/kg, whereas adrenocorticotropic hormone and cortisol reached a peak level at 15 min (from 6.0 ± 0.7 to 18.2 ± 1.5 pmol/l, P < 0.01, and from 4.4 ± 0.9 to 16.5 ± 2.7 x 10-2 μmol/l, P < 0.01, respectively). 6. These results suggest that endothelin is a potent vasoconstrictive peptide in vivo with a marked effect on the renal vascular system, and that it induces elevation of vasoactive hormones directly and/or through central effects.

AB - 1. The effects of endothelin on systemic and renal haemodynamics and plasma concentrations of neuroendocrine hormones including plasma renin activity, aldosterone, adrenocorticotropic hormone, cortisol, catecholamines and arginine vasopressin were investigated in 18 conscious dogs. 2. Bolus injection of 4 pmol of endothelin/kg did not cause any significant changes in haemodynamics. Mean arterial pressure was elevated by both doses of 40 pmol/kg [91 ± 2 to 99 ± 2 mmHg (12.1 ± 0.3 to 13.2 ± 0.3 kPa), P < 0.05] or 200 pmol/kg [93 ± 2 to 107 ± 3 mmHg (12.4 ± 0.3 to 14.3 ± 0.4 kPa), P < 0.01], the latter dose increasing cardiac output (14%, P < 0.05) and heart rate (9%, P < 0.05), and the former reducing these parameters (14% and 8%, P < 0.05, respectively). 3. In contrast with the various changes in systemic haemodynamics, renal blood flow transiently increased immediately after bolus injection in a dose-dependent manner (28%, P < 0.05, 50%, P < 0.01 and 110%, P < 0.01 with 4, 40 and 200 pmol of endothelin/kg, respectively). This transient elevation of renal blood flow was followed by a gradual decrease (16%, P < 0.05; 31%, P < 0.01 and 36%, P < 0.01) at 10 min. 4. All neurohormones were elevated in a dose-dependent manner. 5. Among these hormones, arginine vasopressin and plasma renin activity reached a peak level at 5 min (from 2.21 ± 0.45 to 6.37 ± 0.60 pmol/l, P < 0.01, and from 0.65 ± 0.08 to 1.09 ± 0.10 pmol of angiotensin I h-1 ml-1 P < 0.01, respectively) after bolus injection of 200 pmol of endothelin/kg, whereas adrenocorticotropic hormone and cortisol reached a peak level at 15 min (from 6.0 ± 0.7 to 18.2 ± 1.5 pmol/l, P < 0.01, and from 4.4 ± 0.9 to 16.5 ± 2.7 x 10-2 μmol/l, P < 0.01, respectively). 6. These results suggest that endothelin is a potent vasoconstrictive peptide in vivo with a marked effect on the renal vascular system, and that it induces elevation of vasoactive hormones directly and/or through central effects.

UR - http://www.scopus.com/inward/record.url?scp=0024439304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024439304&partnerID=8YFLogxK

M3 - Article

C2 - 2555107

AN - SCOPUS:0024439304

VL - 77

SP - 567

EP - 572

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 5

ER -